Table III.
GO ID | GO Term | Count | P-value |
---|---|---|---|
Biological process | |||
GO:0030195 | Negative regulation of blood coagulation | 21 | 1.83×10−24 |
GO:1900047 | Negative regulation of hemostasis | 21 | 1.83×10−24 |
GO:0050819 | Negative regulation of coagulation | 21 | 2.65×10−23 |
GO:0042730 | Fibrinolysis | 17 | 1.90×10−22 |
GO:0040023 | Establishment of nucleus localization | 16 | 2.55×10−22 |
GO:0051961 | Negative regulation of nervous system development | 14 | 2.70×10−22 |
GO:0051964 | Negative regulation of synapse assembly | 14 | 2.70×10−22 |
GO:0030198 | Extracellular matrix organization | 35 | 6.31×10−21 |
GO:0043062 | Extracellular structure organization | 35 | 6.58×10−21 |
GO:0051241 | Negative regulation of multicellular organismal process | 40 | 2.08×10−20 |
GO:0001525 | Angiogenesis | 35 | 2.86×10−20 |
GO:0060252 | Positive regulation of glial cell proliferation | 15 | 3.64×10−20 |
GO:0030320 | Cellular monovalent inorganic anion homeostasis | 14 | 3.68×10−20 |
GO:0030644 | Cellular chloride ion homeostasis | 14 | 3.68×10−20 |
GO:0055064 | Chloride ion homeostasis | 14 | 3.68×10−20 |
Cellular component | |||
GO:0042383 | Sarcolemma | 33 | 1.85×10−29 |
GO:0043220 | Schmidt-Lanterman incisure | 18 | 1.80×10−25 |
GO:0035749 | Myelin sheath adaxonal region | 17 | 5.91×10−25 |
GO:0043218 | Compact myelin | 18 | 2.95×10−23 |
GO:0005925 | Focal adhesion | 30 | 1.69×10−21 |
GO:0005924 | Cell-substrate adherens junction | 30 | 3.04×10−21 |
GO:0030055 | Cell-substrate junction | 30 | 1.30×10−20 |
GO:0070161 | Anchoring junction | 32 | 1.09×10−17 |
GO:0005912 | Adherens junction | 31 | 1.73×10−17 |
GO:0043209 | Myelin sheath | 18 | 2.16×10−15 |
GO:0019897 | Extrinsic to plasma membrane | 18 | 2.01×10−13 |
GO:0019898 | Extrinsic to membrane | 18 | 4.02×10−10 |
GO:0030054 | Cell junction | 40 | 1.61×10−09 |
GO:0014704 | Intercalated disc | 14 | 2.10×10−09 |
GO:0044291 | Cell-cell contact zone | 14 | 3.13×10−09 |
Molecular function | |||
GO:0004859 | Phospholipase inhibitor activity | 29 | 1.14×10−44 |
GO:0055102 | Lipase inhibitor activity | 29 | 3.76×10−43 |
GO:0005544 | Calcium-dependent phospholipid binding | 35 | 5.77×10−41 |
GO:0030234 | Enzyme regulator activity | 79 | 1.58×10−23 |
GO:0004857 | Enzyme inhibitor activity | 43 | 1.15×10−22 |
GO:0005509 | Calcium ion binding | 65 | 2.23×10−20 |
GO:0005546 | Phosphatidylinositol-4,5-bisphosphate binding | 18 | 2.28×10−20 |
GO:0005543 | Phospholipid binding | 53 | 7.37×10−19 |
GO:1901981 | Phosphatidylinositol phosphate binding | 19 | 2.81×10−17 |
GO:0008289 | Lipid binding | 56 | 1.54×10−15 |
GO:0043548 | Phosphatidylinositol 3-kinase binding | 14 | 6.81×10−14 |
GO:0008092 | Cytoskeletal protein binding | 51 | 1.35×10−13 |
GO:0017137 | Rab GTPase binding | 17 | 1.55×10−13 |
GO:0004713 | Protein tyrosine kinase activity | 25 | 1.43×10−12 |
GO:0035091 | Phosphatidylinositol binding | 22 | 2.75×10−11 |
GO, Gene Ontology.